Patient engagement in 2030: How can patient engagement contribute towards building a new ecosystem for drug development & therapy?

Samen met HollandBIO

02/12/21


Patient engagement has become one of the key aspects in drug development and therapy during recent years and becomes more important as time progresses. At the same time, these processes are undergoing change towards a new ecosystem. By taking the lessons learned from the past, taking current initiatives and bright ideas for the future, patient engagement plays a crucial role in the future of drug development & therapy. Start your development with the end in mind!

On December 2nd 2021, admedicum Business for Patients will organize an event in collaboration with HollandBIO where patient representatives will set the scene and subsequently multiple stakeholder speakers from healthcare, regulatory and industry will share constructive perspectives towards solutions, improvements and opportunities for patient engagement in 2030. The different perspectives will be followed by an interactive and open ‘parliamentary style’ debate.

Please click here for an overview of the exciting program with international speakers, including Nicola Bedlington (former Secretary General European Patient’ Forum), Cécile Olivier (C-Path), Ana Mingorance (Loulou Foundation), Joep Rijnierse (Amgen) and a representative from Healx.

Practical info

  • Date: 2 December 2021
  • Time: 14:00 doors open, 14:45 program, 17:30 drinks
  • Venue: Muntgebouw Utrecht, the Netherlands
  • Registration will be free

 

Kaart wordt geladen...